control mice were kept in the same room and did not develop any neurological disease. The incubation periods correspond to survival times assessed according to the criteria in (25). 29. Whole brain hemispheres were fixed in buffered 10%
formalin. Pieces of brain were then embedded either in paraffin for immunohistochemistry (7-m sections) or in Araldite (4-m sections) for fine morphological examination. Antibodies were a polyclonal antibody to mouse glial fibrillary acidic protein (GFAP) and a horseradish peroxidase-conjugated secondary antibody (Dako (3) indicate that the estrogenic activities of all the binary mixtures of organochlorine pesticides were additive. These same binary mixtures were also investigated in a yeast-based human ER assay (4), which used the same yeast strain and reporter gene construct used by Arnold et al. (1) . In contrast to that study, synergistic activity was not observed for any pesticide combination. The differences between our results and those reported by Arnold et al.
(1) cannot be accounted for by differences in total ER expression, because varying this expression did not have any affect on synergy. These results demonstrate that synergism between weakly estrogenic chemicals is not universal, even within the same strain of yeast. The recent scientific, regulatory, and public concern regarding the potential adverse environmental and human health impacts from synergistic estrogen responses induced by organochlorine pesticide mixtures should be tempered by our results, which demonstrate that these compounds are weakly estrogenic and, in combination, their activities are additive (5 Response: It is difficult to compare the results of the study by Ramamoorthy et al. to ours because the assays they used, while appearing to be similar to ours, were in each case different. The differences, however, have been instructive in helping us frame some of the parameters that may be important in determining the synergistic action of weakly estrogenic chemicals.
In our mammalian and yeast cell assays (1), as well as in the ligand-binding experiments, the concentration of receptor molecules was low, while in the study by Ramamoorthy et al. the concentrations were high. For example, our mammalian cell culture experiments used Ishikawa uterine cancer cells that lack detectable ER and were transfected with only 20 ng of hER cDNA. In contrast, Ramamoorthy et al. used MCF-7 breast cancer cells that contained high levels of endogenous ERs [MCF-7 cells typically contain endogenous ER levels in the range of 30,000 ERs per cell (2) to 200,000 ERs per cell (3)] and that were transfected with an additional 4 to 5 g of hER cDNA. Likewise, in the yeast-based assay used in our report, the number of expressed hERs was estimated to be 500 to 1000 receptors per cell, but the study by Ramamoorthy et al. appears to contain well in excess of 1000 ERs per cell. Finally, our in vitro competitive binding conditions used 0.4 nM concentrations of ERs (monomer concentrations), whereas the concentration of ER used by Ramamoorthy et al. was apparently 20 to 30 nM (2) and the assays were performed in whole cells. Therefore, because our results showed synergy and theirs did not, ER concentration may play an important role in the ability of mixtures of chemicals to synergize.
With regard to the animal studies, our A mechanism underlying these synergistic effects remains to be determined. One of our working hypotheses is that under conditions in which the ER tends to exist as a monomer, the binding characteristics of two interacting molecules are different from that observed at high receptor concentrations. We contend that this low ER experimental condition better approximates ER concentrations found during early development [the ER content of uterine epithelial cells is low in fetal or newborn mouse (6) or rat (7), a period critical for estrogen-associated disorders (8) ]. During these sensitive periods, chemical interactions resulting in synergy may occur at conditions in which critical ligand-receptor or receptorreceptor combinations occur.
Synergism between weakly estrogenic chemicals may not be universal, as Ramamoorthy et al. suggest. However, synergy in biological systems has a long history. Synergy has been observed between steroid hormones, different nuclear receptors (9), membrane; and nuclear receptors (10), drugs and hormones (11) , and temperature and hormone response (12) . Synergistic interactions have also been observed between drugs and temperature (13) and weakly estrogenic compounds (4). Our discovery of synergy of natural and synthetic estrogens was made by observing the effects of these compounds on the sexual development of turtle embryos. We demonstrated synergy between a combination of two polychlorinated biphenyls (4), and, more recently, two steroidal estrogens (14) . We also have recently reported that the binding of chemical mixtures to the estrogen receptor from the American alligator occurs in a synergistic manner (15) . Our laboratory has shown that a combination of phytoestrogens produced a synergistic response in yeast (16) . In addition, in cell culture studies of fish hepatocytes (17) as well as mammalian cells (18) , mixtures of weakly estrogenic chemicals were shown to act synergistically in stimulating estrogenic responses appropriate to the species. These findings together suggest that the synergistic action of weak estrogens may be phylogenetically conserved and therefore fundamental.
We currently are evaluating the occurrence of synergistic interactions of chemicals with the ER in different yeast strains, mammalian cells, and biological systems. We have noted synergy in some yeast strains, but not others, as well as an apparent relationship to ER concentrations (19) . We have likewise found a synergistic interaction between ovarian steroidal estrogens in both a yeast-based assay and the developing turtle (14) . These latter studies both confirm and extend our previous report (1) and suggest a mechanism for synergy. We look forward to the continued clarification of this important issue. consumption during weathering to be proportional to the global rate of uplift. The rate of O 2 production is highly sensitive to marine reactive P availability through interactions with the carbon cycle. Van Cappellen and Ingall assume that the rate of P input to the oceans depends only on the size of the terrestrial lithosphere reservoir of this element and not on weathering rates. This assumption virtually decouples the rate of oxidative weathering from that of P transfer to the oceans on time scales of tens to hundreds of millions of years and accounts for the rapid depletion in atmospheric O 2 in the model after an increase in uplift rate (Fig. 1) . It seems more likely that the flux of P to the oceans also depends on the rate of uplift. Today, refractory, detrital P phases account for less than 25% of the total solidphase P in most marine sediments (2) , and changes in total continental P weathering rates have apparently led to comparable changes in the chemical weathering of P phases over at least the last 100 million years (My) (3) . When the model (1) is run with P and Fe oceanic inputs coupled to
